Related Experiment Video
Updated: Jul 18, 2026

G Protein-selective GPCR Conformations Measured Using FRET Sensors in a Live Cell Suspension Fluorometer Assay
Published on: September 10, 2016
Conformation state-sensitive antibodies to G-protein-coupled receptors
Achla Gupta1, Fabien M Décaillot, Ivone Gomes
1Department of Pharmacology and Biological Chemistry, Mount Sinai School of Medicine, New York, New York 10029, USA.
Abstract:
A growing body of evidence indicates that G-protein-coupled receptors undergo complex conformational changes upon agonist activation. It is likely that the extracellular region, including the N terminus, undergoes activation-dependent conformational changes. We examined this by generating antibodies to regions within the N terminus of micro-opioid receptors. We find that antibodies to the midportion of the N-terminal tail exhibit enhanced recognition of activated receptors, whereas those to the distal regions do not. The enhanced recognition is abolished upon treatment with agents that block G-protein coupling or deglycosylate the receptor. This suggests that the N-terminal region of mu receptors undergoes conformational changes following receptor activation that can be selectively detected by these region-specific antibodies. We used these antibodies to characterize micro receptor type-specific ligands and find that the antibodies accurately differentiate ligands with varying efficacies. Next, we examined if these antibodies can be used to investigate the extent and duration of activation of endogenous receptors. We find that peripheral morphine administration leads to a time-dependent increase in antibody binding in the striatum and prefrontal cortex with a peak at about 30 min, indicating that these antibodies can be used to probe the spatio-temporal dynamics of native mu receptors. Finally, we show that this strategy of targeting the N-terminal region to generate receptor conformation-specific antisera can be applied to other G(alpha)(i)-coupled (delta-opioid, CB1 cannabinoid, alpha(2A)-adrenergic) as well as G(alpha)(s)-(beta(2)-adrenergic) and G(alpha)(q)-coupled (AT1 angiotensin) receptors. Taken together, these studies describe antisera as tools that allow, for the first time, studies probing differential conformation states of G-protein-coupled receptors, which could be used to identify molecules of therapeutic interest.
Insights
New antibodies targeting the N-terminal region of micro-opioid receptors can detect conformational changes upon activation. These tools help study receptor dynamics and identify potential therapeutics for various G-protein-coupled receptors.
Area of Science:
- Pharmacology
- Biochemistry
- Molecular Biology
Background:
- G-protein-coupled receptors (GPCRs) undergo conformational changes upon activation.
- The extracellular N-terminal region of GPCRs is hypothesized to change conformation during activation.
Purpose of the Study:
- To generate and characterize antibodies targeting specific regions of the micro-opioid receptor N-terminus.
- To investigate if these antibodies can detect activation-dependent conformational changes in GPCRs.
- To explore the utility of these antibodies in studying receptor dynamics and identifying novel therapeutics.
Main Methods:
- Generation of region-specific antibodies against the N-terminal tail of micro-opioid receptors.
- Assessing antibody binding to activated versus non-activated receptors.
- Investigating the effect of G-protein coupling blockers and deglycosylation on antibody recognition.
- Utilizing antibodies to differentiate between micro-opioid receptor ligands with varying efficacies.
- Probing the spatio-temporal dynamics of endogenous receptors in vivo using antibody binding.
- Applying the antibody generation strategy to other GPCRs coupled to different G proteins.
Main Results:
- Antibodies targeting the midportion of the N-terminal tail enhanced recognition of activated micro-opioid receptors.
- This enhanced recognition was abolished by blocking G-protein coupling or deglycosylation.
- Antibodies accurately differentiated ligands based on their efficacies.
- Peripheral morphine administration induced a time-dependent increase in antibody binding in specific brain regions, indicating in vivo applicability.
- The strategy was successfully applied to diverse GPCRs, including delta-opioid, CB1 cannabinoid, alpha(2A)-adrenergic, beta(2)-adrenergic, and AT1 angiotensin receptors.
Conclusions:
- The N-terminal region of mu-opioid receptors undergoes activation-dependent conformational changes detectable by region-specific antibodies.
- These conformation-specific antisera are valuable tools for studying GPCR dynamics, ligand characterization, and identifying molecules of therapeutic interest.
- This approach offers a novel strategy for investigating differential conformational states across various GPCRs.
More Related Videos
Related Concept Videos
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical, 7TM, or...
G-protein Coupled Receptors
G-protein Coupled Receptors
Activation and Inactivation of G Proteins

